Is Gamida Cell Ltd. (GMDA) a Buy, Sell, or Hold?
NASDAQ : GMDA
Gamida Cell Ltd. — Institutional Ownership
$0.0327 USD
$0 (0.0%)
- Volume
- 19.05M
- Average Volume
- 21.71M
- Market Capitalization
- $4.34M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.04
- Year Low
- $0.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.16
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2024-02-08 | but shall be subject to all other provisions of the Act (however, see the notes. | 9.13M | 6.90% |
| 2023-08-24 | Jon M. Plexico | 9.85M | 11.00% |
| 2023-08-24 | Stonepine Capital Management, LLC | 9.85M | 11.00% |
| 2023-08-24 | Timothy P. Lynch | 9.85M | 11.00% |
| 2023-08-24 | Stonepine Capital, L.P. | 9.85M | 11.00% |
| 2023-08-21 | Master Fund, LP | 6.17M | 5.00% |
| 2023-08-21 | US Fund Management, Inc. | 6.17M | 5.00% |
| 2023-08-21 | Blank | 6.17M | 5.00% |
| 2023-05-01 | Jon M. Plexico | 4.74M | 4.40% |
| 2023-05-01 | Stonepine Capital Management, LLC | 4.74M | 4.40% |
| 2023-05-01 | Timothy P. Lynch | 4.74M | 4.40% |
| 2023-05-01 | Stonepine Capital, L.P. | 4.74M | 4.40% |
| 2023-04-24 | Heights Capital Management, Inc. | 7M | 6.60% |
| 2023-04-24 | CVI Investments, Inc. | 7M | 6.60% |
| 2023-02-14 | US Fund Management, Inc. | 5.04M | 6.80% |
| 2023-02-14 | Master Fund, LP | 5.04M | 6.80% |
| 2022-11-15 | Access Industries Holdings LLC | 5.99M | 8.06% |
| 2022-11-15 | AI Gamida Holdings LLC | 3.75M | 5.04% |
| 2022-11-15 | Bio Medical Investment Ltd. | 1.37M | 1.85% |
| 2022-11-15 | Len Blavatnik | 9.74M | 13.10% |
| 2022-11-15 | Access Industries Management, LLC | 9.74M | 13.10% |
| 2022-11-15 | Access Industries, LLC | 5.99M | 8.06% |
| 2022-11-15 | AI Biotechnology LLC | 3.11M | 4.18% |
| 2022-11-15 | Clal Biotechnology Industries Ltd. | 2.88M | 3.87% |
| 2022-02-14 | Mitchell Blutt | - | 0.00% |
| 2022-02-14 | Consonance Capman GP LLC | - | 0.00% |
| 2022-02-14 | Consonance Capital Management LP | - | 0.00% |
| 2022-02-11 | Highbridge Capital Management, LLC | 4.86M | 7.64% |
| 2021-02-26 | Highbridge Capital Management, LLC | 4.22M | 6.66% |
| 2021-02-17 | Consonance Capman GP LLC | 3.29M | 5.57% |
| 2021-02-17 | Mitchell Blutt | 3.29M | 5.57% |
| 2021-02-17 | Consonance Capital Opportunity Fund Management LP | 316.91K | 0.54% |
| 2021-02-17 | Consonance Capital Management LP | 2.97M | 5.04% |
| 2021-02-16 | Mitchell Blutt | 6.06M | 9.99% |
| 2021-02-16 | Consonance Capital Management LP | 2.97M | 5.04% |
| 2021-02-16 | Consonance Capman GP LLC | 6.06M | 9.99% |
| 2021-02-16 | Consonance Capital Opportunity Fund Management LP | 1.19M | 2.04% |
| 2021-02-12 | Thomas R. Donahue | 5.05M | 8.56% |
| 2021-02-12 | Federated Hermes, Inc. | 5.05M | 8.56% |
| 2021-02-12 | J. Christopher Donahue | 5.05M | 8.56% |
| 2021-02-12 | Rhodora J. Donahue | 5.05M | 8.56% |
| 2021-02-12 | Voting Shares Irrevocable Trust | 5.05M | 8.56% |
| 2020-08-14 | Novartis AG | 5.19M | 10.30% |
| 2020-08-14 | Novartis Pharma AG | 5.19M | 10.30% |
| 2020-02-14 | Israel Healthcare Ventures 2 L.P. | 1.92M | 5.70% |
| 2020-02-14 | Paddy M. Whitford | 1.92M | 5.70% |
| 2020-02-14 | Gordon R. L. Snelling | 1.92M | 5.70% |
| 2020-02-14 | IHCV2 General Partner Limited | 1.92M | 5.70% |
| 2020-02-07 | Abigail P. Johnson | 2.88M | 8.67% |
| 2020-02-07 | FMR LLC | 2.88M | 8.67% |
| 2019-04-09 | SMARTMIX LIMITED | 2.86M | 11.30% |
| 2019-02-14 | Gabriel Leibler | 2.74M | 10.70% |
| 2019-02-14 | Ltd. Partnership | 2.69M | 10.77% |
| 2019-02-14 | Ltd. | 2.69M | 10.77% |
| 2019-02-14 | Technologies Ltd. | 2.69M | 10.77% |
| 2019-02-14 | Gabriel Capital Management Ltd. | 2.68M | 10.50% |
GMDA Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-12-31 | $0.41 | 148.58M | $61.32M | $46.55M | $82.94M | $97.71M |
| 2022-12-31 | $1.29 | 63.83M | $82.34M | $64.66M | $103.96M | $121.64M |
| 2021-12-31 | $2.54 | 59.25M | $150.49M | $55.89M | $79.72M | $174.31M |
| 2020-12-31 | $8.39 | 43.73M | $366.86M | $127.17M | $7.91M | $247.6M |
| 2019-12-31 | $4.30 | 29.46M | $126.68M | $41.84M | $5.97M | $90.81M |
| 2018-12-31 | $9.94 | 24.97M | $248.21M | $40.27M | -$ | $207.94M |
| 2017-12-31 | $8.44 | 17.97M | $151.69M | $21.32M | -$ | $130.37M |
| 2016-12-31 | $8.44 | 17.97M | $151.69M | $18.06M | -$ | $133.63M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-03-31 | $0.04 | 152.71M | $5.7M | $24.78M | $78.09M | $59.01M |
| 2023-12-31 | $0.41 | 144.44M | $59.61M | $49.61M | $82.94M | $92.94M |
| 2023-09-30 | $1.03 | 124.24M | $127.96M | $60.43M | $85.22M | $152.75M |
| 2023-06-30 | $1.93 | 102.92M | $198.64M | $54.08M | $90.75M | $235.32M |
| 2023-03-31 | $0.81 | 76.76M | $62.18M | $46.76M | $95.7M | $111.12M |
| 2022-12-31 | $1.29 | 74.58M | $96.21M | $64.66M | $103.96M | $135.52M |
| 2022-09-30 | $1.59 | 60.44M | $96.1M | $55.07M | $78.05M | $119.08M |
| 2022-06-30 | $1.77 | 59.55M | $105.4M | $37.89M | $78.55M | $146.06M |
| 2022-03-31 | $4.15 | 59.47M | $246.82M | $42.06M | $79.34M | $284.11M |
| 2021-12-31 | $2.54 | 59.28M | $150.57M | $55.89M | $79.72M | $174.4M |
| 2021-09-30 | $3.92 | 59.28M | $232.38M | $80.61M | $70.92M | $222.69M |
| 2021-06-30 | $6.41 | 59.25M | $379.81M | $100.49M | $70.96M | $350.29M |